← Back to headlines
Amtagvi Approval Boosts Iovance Biotherapeutics (IOVA), Rally Sustainability Questioned
The approval of Amtagvi has boosted Iovance Biotherapeutics, Inc. (IOVA) stock, but the article questions whether this rally can be sustained in the long term.
13 Jun, 15:30 — 13 Jun, 15:30
Sources
Showing 1 of 1 sources
